Harriet Clarfelt

The Aim-traded group acquired a tech business last year which could help improve quality of care

Fidelity will not accept the bid at its current level, but there are doubts about who else will table an offer

Aim-traded shares in the group slipped 25 per cent in morning trading

With Portugal downgraded to amber, carriers’ shares have taken another hit

The group’s opportunities extend beyond its successful Covid-19 vaccine developed in partnership with BioNTech

Both companies have been bolstered by the need to address animal health and environmental concerns pertaining to farming

The healthcare services company posted a 5 per cent drop in revenues as PE interest emerged

Could a mooted IP vaccine waiver have implications for the broader pharma sector?

The family-controlled sports fashion group has shown resilience during the pandemic

Various pharma companies have updated in the last week, shining a light on inflammatory conditions